David G. Daniel

5.3k total citations · 1 hit paper
91 papers, 3.9k citations indexed

About

David G. Daniel is a scholar working on Psychiatry and Mental health, Clinical Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, David G. Daniel has authored 91 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Psychiatry and Mental health, 17 papers in Clinical Psychology and 13 papers in Experimental and Cognitive Psychology. Recurrent topics in David G. Daniel's work include Schizophrenia research and treatment (47 papers), Bipolar Disorder and Treatment (14 papers) and Mental Health Research Topics (12 papers). David G. Daniel is often cited by papers focused on Schizophrenia research and treatment (47 papers), Bipolar Disorder and Treatment (14 papers) and Mental Health Research Topics (12 papers). David G. Daniel collaborates with scholars based in United States, United Kingdom and Canada. David G. Daniel's co-authors include Stephen R. Marder, Angel Cienfuegos, Gregory P. Strauss, Brian Kirkpatrick, Bernard A. Fischer, Linh P. Nguyen, Daniel R. Weinberger, Daniel E. Casey, Patricia Wozniak and Sonja M. McKinlay and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Stroke.

In The Last Decade

David G. Daniel

86 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Brief Negative Symptom Scale: Psychometric Properties

2010 640 citations Brian Kirkpatrick, Gregory P. Strauss et al. Schizophrenia Bulletin profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David G. Daniel	2.7k	678	524	522	483	91	3.9k
Rachel Upthegrove	2.1k 0.7×	1.1k 1.6×	599 1.1×	659 1.3×	386 0.8×	142	4.2k
Takefumi Suzuki	2.6k 1.0×	766 1.1×	430 0.8×	374 0.7×	416 0.9×	234	4.6k
Katja Komossa	3.0k 1.1×	756 1.1×	449 0.9×	526 1.0×	519 1.1×	26	4.3k
Vicent Balanzá‐Martínez	2.9k 1.1×	989 1.5×	390 0.7×	449 0.9×	184 0.4×	130	4.7k
Rocío Pérez‐Iglesias	2.9k 1.0×	537 0.8×	276 0.5×	1.2k 2.2×	480 1.0×	106	4.2k
Jose Ma. J. Alvir	3.1k 1.1×	1.2k 1.8×	360 0.7×	823 1.6×	738 1.5×	37	4.4k
S.R. Marder	2.4k 0.9×	692 1.0×	602 1.1×	499 1.0×	821 1.7×	45	3.2k
Sukanta Saha	2.4k 0.9×	923 1.4×	257 0.5×	323 0.6×	621 1.3×	26	4.0k
Rafael Tabarés‐Seisdedos	4.6k 1.7×	1.0k 1.5×	496 0.9×	949 1.8×	294 0.6×	157	6.5k
Miro Jakovljević	1.3k 0.5×	1.3k 1.9×	286 0.5×	324 0.6×	165 0.3×	188	3.8k

Countries citing papers authored by David G. Daniel

Since Specialization

Citations

This map shows the geographic impact of David G. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Daniel more than expected).

Fields of papers citing papers by David G. Daniel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Daniel. The network helps show where David G. Daniel may publish in the future.

Co-authorship network of co-authors of David G. Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Daniel. A scholar is included among the top collaborators of David G. Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Daniel. David G. Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dufton, Christopher, Marc Evanchik, David G. Daniel, et al.. (2025). EDG-7500, A First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, And Pharmacokinetics In Healthy Adults. Journal of Cardiac Failure. 31(1). 345–345. 3 indexed citations

Daniel, David G., Alex S. Cohen, Philip D. Harvey, et al.. (2024). Rationale and Challenges for a New Instrument for Remote Measurement of Negative Symptoms. Schizophrenia Bulletin Open. 5(1). sgae027–sgae027. 2 indexed citations

Youngstrom, Eric A., et al.. (2024). Replicating and Extending the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials. PubMed. 3(2). 257–267. 2 indexed citations

Daniel, David G., et al.. (2024). Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA. Stroke and Vascular Neurology. 10(1). 65–70.

Daniel, David G., Alex S. Cohen, Dawn I. Velligan, et al.. (2023). Remote Assessment of Negative Symptoms of Schizophrenia. Schizophrenia Bulletin Open. 4(1). sgad001–sgad001. 5 indexed citations

Daniel, David G., et al.. (2023). Patterns and outcomes of weekend admission for acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 32(9). 107250–107250. 1 indexed citations

Findling, Robert L., Eric A. Youngstrom, Jon McClellan, et al.. (2022). An Optimized Version of the Positive and Negative Symptoms Scale (PANSS) for Pediatric Trials. Journal of the American Academy of Child & Adolescent Psychiatry. 62(4). 427–434. 4 indexed citations

Earley, Willie, Hua Guo, David G. Daniel, et al.. (2018). Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data. Schizophrenia Research. 204. 282–288. 53 indexed citations

Daniel, David G., et al.. (2017). Positive and Negative Syndrome Scale (PANSS) Training. 14. 3 indexed citations

10.

Targum, Steven D., Pamela Wedel, Jill O. Robinson, et al.. (2013). A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive Disorder. Journal of Psychiatric Research. 47(7). 944–954. 26 indexed citations

11.

Daniel, David G., Larry Alphs, Pilar Cazorla, John J. Bartko, & John Panagides. (2011). Training for Assessment of Negative Symptoms of Schizophrenia across Languages and Cultures: Comparison of the NSA-16 with the PANSS Negative Subscale and Negative Symptom Factor. Clinical Schizophrenia & Related Psychoses. 5(2). 87–94. 19 indexed citations

12.

Kirkpatrick, Brian, Gregory P. Strauss, Linh P. Nguyen, et al.. (2010). The Brief Negative Symptom Scale: Psychometric Properties. Schizophrenia Bulletin. 37(2). 300–305. 640 indexed citations breakdown →

13.

Casey, Daniel E., David G. Daniel, Carol A. Tamminga, et al.. (2008). Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia. Neuropsychopharmacology. 34(5). 1330–1338. 41 indexed citations

14.

Daniel, David G., Glenn W. Currier, Dan Zimbroff, et al.. (2007). Efficacy and Safety of Oral Aripiprazole Compared with Haloperidol in Patients Transitioning from Acute Treatment with Intramuscular Formulations. Journal of Psychiatric Practice. 13(3). 170–177. 20 indexed citations

15.

Currier, Glenn W., Michael H. Allen, E. Bradshaw Bunney, et al.. (2004). Future directions in research. Journal of Emergency Medicine. 27(4). S27–S29. 1 indexed citations

16.

Currier, Glenn W., Michael H. Allen, E. Bradshaw Bunney, et al.. (2004). Intramuscular antipsychotics: Clinical experience review. Journal of Emergency Medicine. 27(4). S3–S4. 5 indexed citations

17.

Weiden, Peter J., David G. Daniel, George M. Simpson, & Steven J. Romano. (2003). Improvement In Indices Of Health Status In Outpatients With Schizophrenia Switched To Ziprasidone. Journal of Clinical Psychopharmacology. 23(6). 595–600. 96 indexed citations

18.

Powell, Richard, et al.. (2000). The effects of upper body weight support upon cardiovascular, metabolic and electromyographic variables during assisted walking1. International Journal of Rehabilitation Research. 23(1). 129–134.

19.

Fujishima, Seitaro, Andrew R. Hoffman, Thanh Vu, et al.. (1993). Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF‐α, and IL‐1β. Journal of Cellular Physiology. 154(3). 478–485. 134 indexed citations

20.

Daniel, David G., Terry E. Goldberg, Robert D. Gibbons, & Daniel R. Weinberger. (1991). Lack of a bimodal distribution of ventricular size in schizophrenia: A Gaussian mixture analysis of 1056 cases and controls. Biological Psychiatry. 30(9). 887–903. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact